Defibrillator is an essential tool in cardiopulmonary resuscitation indicated in cardiac arrhythmia. Various advancements have been observed in defibrillator technology – from manual to automated ones, and implantable defibrillators to ensure constant care for patients suffering from ischemic heart disease or those at high risk of cardiac arrest. A Global Resuscitation Alliance (GRA) was formed in 2016, comprising international health organizations, global resuscitation leaders, and the American Heart Association (AHA), with an objective to increase the survival rate of patients with sudden cardiac arrest, by 50%. This alliance actively works towards increasing public awareness about defibrillators and has facilitated the installation of automated defibrillators in public places for use in case of related medical emergencies. Training initiatives such as by-stander PCR training by manufacturers would considerably contribute towards improvement in survival rates, while enhancing brand visibility.
Onboard emergency medical cases lead to major losses to airlines. Emirates handled more than 60 flight diversions in 2016 due to medical emergency and it is estimated that a single diversion could lead to losses ranging from US$ 50,000 to US$ 600,000. The airline therefore decided to set standards for emergency medical care in 2016 and have invested US$ 7 million for installing medical equipment on board which also include defibrillators.
Request Sample Copy of Research Report @ https://www.coherentmarketinsights.com/insight/request-sample/115
Heart related disorders such as cardiac arrhythmias and sudden cardiac arrests are common globally due to drastic lifestyle changes and unhealthy eating habits. The abovementioned factors are precursors for cardiac disorders, which can gradually deteriorate heart health. Furthermore, rising number of cardiovascular disorders are expected to support the market for defibrillators over the forecast period. Also, rise in elderly population in various regions is projected to underpin the defibrillator market in the near future. Furthermore, the companies involved in the manufacture of such devices are actively promoting their products by installing automated external defibrillators in various public places across the U.S. and U.K. for use in emergency situations. This has significantly improved public understanding about such products and enhanced visibility of specific brands. This is a major factor projected to support growth of the defibrillator market in the near future.
Increasing demand for portable devices due to low survival rates among cardiac arrest patients is expected to drive growth of the global defibrillators market
According to a report by the Institute of Medicine in 2015, around 600 thousand people in the U.S. suffer from cardiac arrest annually, with over 65% of the cases in out-of-hospital settings. The survival rate of out-of-hospital setting is less than 6%, while it is 24% in hospital settings. The survival rate in out-of-hospital setting is less due to consumer’s lack of operational knowledge about defibrillators and about carrying out CPR. Therefore, various training initiatives associated with the use of defibrillators and CPR techniques has led to increasing demand for defibrillators, especially the automated ones, thereby driving growth of the market. Individuals and staffs in malls were given training on how to use defibrillators by the UAE government, who deployed defibrillators in the country. According to the American Heart Association, lack of availability of trained/skilled by-stander at the emergency site is the major factor for less survival rate of patients who suffer from sudden cardiac arrest by 7% – 10% with every minute of delay until defibrillation. Therefore, initiatives to increase awareness and accessibility to the device is expected to fuel the defibrillators market growth.
Key companies covered as a part of this study include Medtronic, St. Jude Medical, Koninklijke Philips N.V., Schiller AG, Cardioline SpA, Mindray Medical, ZOLL Medical Corporation, Boston Scientific Corporation, GE Healthcare and Bexen Cardio
Ask For Discount Before Purchasing This Business Report @ https://www.coherentmarketinsights.com/insight/request-discount/115